Trial Profile
A retrospective, observational study to evaluate the effect of Ustekinumab in patients with anti-TNF-resistant Crohn's Disease: A real life experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 07 Dec 2015 New trial record